No specific drugs have been approved for coronavirus disease 2019 (COVID-19) to date as
the development of antivirals usually requires time. Therefore, assessment and use of …

The current coronavirus disease-2019 (COVID-19) pandemic presents a huge challenge for
health-care systems worldwide. Many different risk factors are associated with disease …

Protein kinases play a major role in cellular activation processes, including signal
transduction by diverse immunoreceptors. Given their roles in cell growth and death and in …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-sense,
single-stranded RNA virus that causes the potentially lethal Covid-19 respiratory tract …

In December 2019, a novel coronavirus pneumonia (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) suddenly broke out in China and rapidly …

Hyperinflammation is associated with increased mortality in coronavirus disease 2019
(COVID-19). In this retrospective, uncontrolled patient cohort with moderate-severe COVID …

The coronavirus disease 2019 (COVID‐19) outbreak is a major threat to human beings.
Lung injury has been reported as the major outcome of COVID‐19 infection. However, liver …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious and
pathogenic virus that first appeared in late December 2019. This SARS-CoV-2 causes an …

Abstract In December 2019, China reported the first cases of the coronavirus disease 2019
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …

SARS-CoV-2 is the agent responsible for COVID-19. The infection can be dived into three
phases: mild infection, the pulmonary phase and the inflammatory phase. Treatment options …